INSULTDA D-DIMER, GFAP VA FAST SHKALASINING DIAGNOSTIK VA PROGNOSTIK AHAMIYATI (ADABIYOTLAR SHARHI)
##article.subject##:
insult, ishemik insult, intraserebral qon quyilish, FAST, BE-FAST, FAST-ED, GFAP, D-dimer, biomarkerlar, kasalxonagacha triaj.##article.abstract##
Sharhda insultni kasalxonagacha bosqichda aniqlashda FAST shkalasi va modifikatsiyalari (BE-FAST, FAST-ED), glial fibrillyar nordon oqsil (GFAP) hamda D-dimerning ahamiyati tahlil qilingan. GFAP intraserebral qon quyilishni yuqori oʻziga xoslik bilan koʻrsatadi, D-dimer yirik tomir okklyuziyasi, etiologiya va prognoz bilan bogʻliq. Uchala komponentni birga qoʻllash triaj aniqligini oshiradi, ammo neyrovizualizatsiya oʻrnini bosmaydi.
Библиографические ссылки
Abdelhak A., Foschi M., Abu-Rumeileh S., et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158-172.
Akbar M., Damayanti F., Tammasse J., et al. Plasma D-dimer as a biomarker for the early classification of common acute ischemic stroke subtypes in Indonesia. Egypt J Neurol Psychiatr Neurosurg. 2023;59:115. doi:10.1186/s41983-023-00720-9.
Almubayyidh M., Jenkins D.A., Gaude E., Parry-Jones A.R. Integrating clinical predictors and glial fibrillary acidic protein in prediction models for the prehospital identification of intracerebral haemorrhage in suspected stroke. BMJ Neurol Open. 2025;7(1):e001160. doi:10.1136/bmjno-2025-001160.
Aroor S., Singh R., Goldstein L.B. BE-FAST (Balance, Eyes, Face, Arm, Speech, Time): reducing the proportion of strokes missed using the FAST mnemonic. Stroke. 2017;48(2):479-481. doi:10.1161/STROKEAHA.116.015169.
Asif K.S., Otite F.O., Desai S.M., et al. Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): a Mission Thrombectomy (MT-2020 Plus) study. Circulation. 2023;148(16):1208-1220. doi:10.1161/CIRCULATIONAHA.122.063366.
Azurmendi L., Gonzalez-Fraile J., Barragán-Prieto A., et al. High-specificity identification of large vessel occlusion stroke using D-dimer and NT-proBNP combined with clinical variables. Front Neurol. 2026;17:1830051. doi:10.3389/fneur.2026.1830051.
Bang O.Y., Seok J.M., Kim S.G., et al. Ischemic stroke and cancer: stroke severely impacts cancer patients, while cancer increases the number of strokes. J Clin Neurol. 2011;7(2):53-59. doi:10.3988/jcn.2011.7.2.53.
Bazarian J.J., Biberthaler P., Welch R.D., et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17(9):782-789.
Cabezas J.A., Bustamante A., Giannini N., et al. Discriminative value of glial fibrillar acidic protein (GFAP) as a diagnostic tool in acute stroke. Individual patient data meta-analysis. J Investig Med. 2020;68(8):1379-1385. doi:10.1136/jim-2020-001432.
Durrani Y., Gerstl J.V.E., Murphy D., et al. Prospective validation of glial fibrillary acidic protein, D-dimer, and clinical scales for acute large-vessel occlusion ischemic stroke detection. Stroke Vasc Interv Neurol. 2024;4:e001304. doi:10.1161/SVIN.123.001304.
European Academy of Neurology. Country profile of Uzbekistan. Neurological diseases in Europe and Uzbekistan: key data and trends from 2021 (Global Burden of Disease Study). Vienna: EAN; 2025. URL: https://www.ean.org/fileadmin/user_upload/ean/ean/research/resources/Country_Factsheets/Fact_Sheet_2025_Uzbekistan_10 06.pdf
Feigin V.L., Brainin M., Norrving B., et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025;20(2):132-144. doi:10.1177/17474930241308142.
Foerch C., Curdt I., Yan B., et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry. 2006;77(2):181-184.
Foerch C., Niessner M., Back T., et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem. 2012;58(1):237-245.
Froehler M.T., Saver J.L., Zaidat O.O., et al. Interhospital transfer before thrombectomy is associated with delayed treatment and worse outcome in the STRATIS registry. Circulation. 2017;136(24):2311-2321.
Gaude E., Murphy D., Gerstl J.V.E., et al. Detection of GFAP and D-dimer in a point-of-care test for large vessel occlusion ischemic stroke. Stroke Vasc Interv Neurol. 2025;5:e001559. doi:10.1161/SVIN.124.001559.
Gaude E., Nogueira B., Ladreda Mochales M., et al. A novel combination of blood biomarkers and clinical stroke scales facilitates detection of large vessel occlusion ischemic strokes. Diagnostics (Basel). 2021;11(7):1137. doi:10.3390/diagnostics11071137.
GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973-1003.
Ghosh A., Nawabi N.L.A., Alcedo D., et al. Prehospital detection of large vessel occlusion and intracerebral hemorrhage using a dual-biomarker point-of-care test. Stroke Vasc Interv Neurol. 2026. doi:10.1161/SVIN.125.002170.
Goyal M., Menon B.K., van Zwam W.H., et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731.
Harbison J., Hossain O., Jenkinson D., et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke. 2003;34(1):71-76.
Italia T., et al. Blood biomarkers for large vessel occlusions: a systematic review. Stroke Vasc Interv Neurol. 2025. doi:10.1161/SVIN.125.001863.
Jæger H.S., Tranberg D., Larsen K., et al. Diagnostic performance of glial fibrillary acidic protein and prehospital stroke scale for identification of stroke and stroke subtypes in an unselected patient cohort with symptom onset < 4.5 h. Scand J Trauma Resusc Emerg Med. 2023;31(1):1.
Kamtchum-Tatuene J., Jickling G.C. Blood biomarkers for stroke diagnosis and management. Neuromolecular Med. 2019;21(4):344-368.
Kim S.G., Hong J.M., Kim H.Y., et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010;41(4):798-801.
Kumar A., Misra S., Yadav A.K., et al. Role of glial fibrillary acidic protein as a biomarker in differentiating intracerebral haemorrhage from ischaemic stroke and stroke mimics: a meta-analysis. Biomarkers. 2020;25(1):1-8.
Lima F.O., Silva G.S., Furie K.L., et al. Field Assessment Stroke Triage for Emergency Destination: a simple and accurate prehospital scale to detect large vessel occlusion strokes. Stroke. 2016;47(8):1997-2002.
Luger S., Witsch J., Dietz A., et al. Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke. Clin Chem. 2017;63(1):377-385.
Mattila O.S., Ashton N.J., Blennow K., et al. Ultra-early differential diagnosis of acute cerebral ischemia and hemorrhagic stroke by measuring the prehospital release rate of GFAP. Clin Chem. 2021;67(10):1361-1372.
Nguyen T.T.M., van den Wijngaard I.R., Bosch J., et al. Comparison of prehospital scales for predicting large anterior vessel occlusion in the ambulance setting. JAMA Neurol. 2021;78(2):157-164. doi:10.1001/jamaneurol.2020.4418.
Paul J.F., Ducroux C., Correia P., et al. Serum glial fibrillary acidic protein in acute stroke: feasibility to determine stroke-type, timeline and tissue-impact. Front Neurol. 2024;15:1470718.
Pérez de la Ossa N., Abilleira S., Jovin T.G., et al. Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas: the RACECAT randomized clinical trial. JAMA. 2022;327(18):1782-1794.
Perry L.A., Lucarelli T., Penny-Dimri J.C., et al. Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: systematic review and meta-analysis of diagnostic test accuracy. Int J Stroke. 2019;14(4):390-399.
Powers W.J., Rabinstein A.A., Ackerson T., et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines. Stroke. 2019;50(12):e344-e418.
Ramos-Pachón A., López-Cancio E., Bustamante A., et al. D-dimer as predictor of large vessel occlusion in acute ischemic stroke. Stroke. 2021;52(3):852-858.
Rennert R.C., Wali A.R., Steinberg J.A., et al. Epidemiology, natural history, and clinical presentation of large vessel ischemic stroke. Neurosurgery. 2019;85(Suppl 1):S4-S8.
Saver J.L. Time is brain — quantified. Stroke. 2006;37(1):263-266.
Saver J.L., Goyal M., van der Lugt A., et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316(12):1279-1288.
Shaw L., Binks R., Burgess D., et al. Diagnostic accuracy of lateral flow blood tests to detect large vessel occlusion stroke. Stroke Vasc Interv Neurol. 2026;6(3):e002233. doi:10.1161/SVIN.125.002233.
Smith E.E., Kent D.M., Bulsara K.R., et al. Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018;49(3):e111-e122.
Weitz J.I., Fredenburgh J.C., Eikelboom J.W. A test in context: D-dimer. J Am Coll Cardiol. 2017;70(19):2411-2420.
Yuan B., Yang T., Yan T., et al. Relationships between D-dimer levels and stroke risk as well as adverse clinical outcomes after acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Front Neurol. 2021;12:670730. doi:10.3389/fneur.2021.670730.
